Climate change is rapidly altering the agricultural landscape, leaving farmers scrambling to adjust. As temperatures rise, ...

CRISPR technology has revolutionised genetic engineering, offering unprecedented precision in DNA editing with vast implications for medicine, agriculture and conservation. Yet, its power demands ...

A Peninsula biotech company raised $68 million from investors — including a venture philanthropy fund started by Lululemon ...

Human extracellular matrices can be edited in their composition using the CRISPR/Cas9 system, leading to materials exhibiting tailored regenerative capacities.

Like people, bacteria get invaded by viruses. In bacteria, the viral invaders are called bacteriophages, derived from the ...

Bacteria steal DNA from silent viruses and use it like a memory bank. That memory helps them protect future generations.

Expanding CRISPR's Potential Since its discovery, CRISPR (“Clustered Regularly Interspaced Short Palindromic Repeats”), which ...

Researchers from the J. Craig Venter Institute (JCVI), the Friedrich-Loeffler-Institut (FLI), and the International Livestock ...

On Tuesday, the team behind the plan to bring mammoth-like animals back to the tundra announced the creation of what it is ...

Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into the roles that specific genes play in many diseases. But to date this ...

In this article, we are going to look at where CRISPR Therapeutics AG (NASDAQ:CRSP) stands against other biotech stocks. Biotech Sector Set for Growth Amid Innovation and Investor Interest The ...

CRISPR Therapeutics AG (CRSP) closed at $41.17 in the latest trading session, marking a -1.84% move from the prior day.